IFNLR1 and neoplasm: The selective downregulation of IFNLR1 expression in cancer cells could be seen as an immune escape mechanism evolved during cancer development which allows cancer cells to secrete IFNλ to support immunomodulation of the tumor microenvironment while avoiding being affected themselves.